The Impact of Evolving Treatment Options in Multiple Myeloma, Part 2
Ryan Haumschild, PharmD, MS, MBA, comments on the use of triplet regimens as the standard of care treatment for patients with multiple myeloma, and Thomas Ollis, MS, RPh, shares a community practice perspective.
The Impact of Evolving Treatment Options in Multiple Myeloma, Part 1
Joseph Mikhael, MD, reviews the history of multiple myeloma treatment and comments on the evolution of care.
